Perrigo Updates Segment Reporting and Profitability Metrics
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Perrigo Company ( (PRGO) ) has issued an announcement.
On February 26, 2026, Perrigo said it has overhauled its segment reporting to align with its product categories rather than geography, effective from the first quarter of 2026. The group now reports Self Care, Specialty Care and Infant Formula as core segments, with Oral Care and Dermacosmetics folded into an “All Other” bucket, mirroring how top management allocates resources and manages growth and profitability.
The company’s chief decision maker also shifted the primary profitability metric from segment operating income to segment adjusted operating income, though Perrigo stressed the changes do not alter historical consolidated financial position, results or cash flows. To aid comparability for investors, Perrigo has provided unaudited recast segment financial data for each quarter from March 2024 through December 2025, noting that some amounts may differ from previously disclosed figures due to redefined categories and updated allocation methods.
The most recent analyst rating on (PRGO) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on Perrigo Company stock, see the PRGO Stock Forecast page.
Spark’s Take on PRGO Stock
According to Spark, TipRanks’ AI Analyst, PRGO is a Neutral.
PRGO scores weak-to-midrange primarily due to deteriorating profitability and declining revenue trends, despite positive cash generation and reduced balance-sheet leverage. Technicals are strongly bearish with the stock trading below key moving averages and negative momentum indicators. Guidance suggests a challenging 2026 transition year with notable near-term EPS headwinds and impairment risk, while the very high dividend yield and extended revolver maturity provide partial support.
To see Spark’s full report on PRGO stock, click here.
More about Perrigo Company
Perrigo Company plc is a consumer self-care and healthcare products maker, focused on over‑the‑counter medicines, wellness items and infant nutrition. Its portfolio spans pain and sleep remedies, upper respiratory and digestive health products, vitamins and supplements, oral electrolyte beverages, women’s and skin health brands, dermacosmetics and infant formula, sold primarily to consumers seeking self‑treatment solutions.
Average Trading Volume: 3,290,974
Technical Sentiment Signal: Sell
Current Market Cap: $1.66B
Learn more about PRGO stock on TipRanks’ Stock Analysis page.
